FOLLOWING is an outline of countries that have restricted or suspended the use of COVID-19 vaccines from AstraZeneca and Johnson & Johnson, after Europe confirmed possible links to rare blood clots.
J&J and AstraZeneca have stated that no clear causal relationship has been established between their vaccines and such blood clots. The European Medicines Agency maintains that the benefits of both shots outweigh any risks.
COUNTRIES USING THE ASTRAZENECA VACCINE WITH RESTRICTIONS
AUSTRALIA
Recommended on April 8 that people under 50 should get Pfizer's COVID-19 vaccine rather than AstraZeneca's.
BRITAIN
Vaccination committee has said an alternative should be given for people under 30 where possible, but that people who have received a first dose of the vaccine should get a second shot.
BULGARIA
Suspended use of vaccine on April 19 for women below 60 years who are at increased risk of thrombosis.
CANADA
Said in early April it would pause offering the vaccine to people under 55 and require a new analysis of the shot.
ESTONIA
Suspended use for people under 60 on April 7.
FRANCE
Is using vaccine only for people aged 55 and over. On April 9, recommended that people under 55 who have had a first dose of the AstraZeneca shot should receive a messenger RNA vaccine for their second dose.
FINLAND
Is using only for people aged 65 and over.
GEORGIA
Is using only in medical centres Russian news agency TASS reported on March 19.
GERMANY
Restricts use to those aged over 60. Recommended on April 1 that people under 60 who have had a first dose of AstraZeneca should receive a different second shot.
INDONESIA
Is using the vaccine but has warned against giving it to people with a low blood platelet count.
IRELAND
Said on April 12 it was restricting use of the vaccine to those over 60.
ITALY
Recommends use only for people over 60.
MEXICO
Drug regulator Cofepris said on April 7 it did not "at this time" plan to limit the vaccine's use but was investigating the information raised by Britain.
NETHERLANDS
Said on April 8 it would limit use of the vaccine to people over 60.
NORTH MACEDONIA
Health minister said on March 31 the vaccine would be limited to people aged over 60 as a precautionary measure.
PHILIPPINES
Said on April 19 it would resume administering the vaccine to under-60s after having temporarily suspended use on April 8.
SOUTH KOREA
Resumed use of the shot for people aged 30 or older on April 12 after suspending use in under-60s on April 7.
SPAIN
From April 8, giving the vaccine only to people over 60.
SWEDEN
Using for people aged 65 and older.
COUNTRIES WHERE ASTRAZENECA VACCINE USE IS SUSPENDED
CAMEROON
Said on March 18 it was suspending administration of shots the country was due to receive.
DENMARK
Said on April 14 it would stop using the AstraZeneca vaccine, the first country to do so. On April 19, Ritzau news agency reported that authorities may permit people to choose to have the vaccine.
NORWAY
The government suspended administration of the shot on March 11 and is assessing whether to follow an Institute of Public Health recommendation to end its use.
J&J VACCINE - REVIEWS, DELAYS AND USE
EUROPEAN UNION
J&J said on April 20 it would resume rollout of the vaccine in Europe with a safety warning after regulators said they found a possible link to rare blood clotting issues but backed its overall benefits against any risks.
Use in the EU was not yet widespread as the company began deliveries only in the week of April 12. At least seven EU countries resumed use of the vaccine following the regulator's decision.
COUNTRIES THAT HAVE RESUMED USE OF J&J VACCINE
UNITED STATES
Health regulators said on April 23 the country can immediately resume use of the J&J vaccine, ending a 10-day pause.
BULGARIA
Decided on April 26 to start administering the vaccine without any restrictions following U.S. FDA ruling.
FRANCE
Government said on April 21 that it plans to start using the vaccine the following week.
GERMANY
The health ministry said on April 21 it will soon start delivering the vaccine to federal states for use in vaccination centres. On April 23, the country decided not to impose limits on use.
GREECE
Plans to start rollout on May 5 after suspending vaccinations on April 19.
ITALY
Health ministry on April 20 recommended the vaccine be used for people over the age of 60.
NETHERLANDS
Resumed use of the vaccine from April 21.
POLAND
Started administering the J&J shot on April 15, saying benefits outweigh potential risks.
SOUTH AFRICA
Researchers will on April 28 resume a study further evaluating the efficacy of the J&J vaccine in the field.
SPAIN
Spanish regions began using the vaccine to inoculate 70-79 year olds on April 22.
COUNTRIES WHERE RESTRICTIONS CONTINUE ON J&J VACCINE
BELGIUM
Delayed J&J rollout at the company's request on April 14.
DENMARK
The health authority said on April 21 it expects to announce its decision the following week.
SWEDEN
The Public Health Agency said on April 19 it was extending its recommendation against starting vaccinations.
Reuters
Wed Apr 28 2021
J&J and AstraZeneca have stated that no clear causal relationship has been established between their vaccines and such blood clots. REUTERSpic
Suruhanjaya Eropah saman Hungary atas dakwaan pelanggaran hak asasi
Budapest gagal hilangkan kebimbangan mengenai undang-undang baharu Hungary yang bertujuan mengehadkan pembiayaan asing bagi kempen politik.
PM Pakistan gembira atas perbincangan produktif dengan PM Malaysia
Bidang-bidang utama itu termasuk perdagangan, IT, tenaga, pertanian, eksport daging halal, pelancongan, pendidikan dan pertahanan.
Rwanda catat 7 lagi kes virus Marburg dan satu lagi kematian
Rwanda mencatatkan tujuh kes baharu penyakit virus Marburg dan satu lagi kematian.
Menurut angka terkini yang dikeluarkan lewat Rabu Kementerian Kesihatan Rwanda,
jumlah keseluruhan jangkitan virus Marburg sejak wabak bermula kini sebanyak 36 kes, dengan 11 kematian dilaporkan setakat ini.
Menurut angka terkini yang dikeluarkan lewat Rabu Kementerian Kesihatan Rwanda,
jumlah keseluruhan jangkitan virus Marburg sejak wabak bermula kini sebanyak 36 kes, dengan 11 kematian dilaporkan setakat ini.
Lebih 140 sekolah UNRWA diserang sejak 7 Oktober
Lebih 140 sekolah UNRWA diserang sejak 7 Oktober dalam keadaan dimana penduduk Gaza berlindung di bawah naungan PBB.
Perkara itu dimaklumkan Pesuruhjaya Agung Agensi Bantuan dan Kerja Pertubuhan Bangsa-Bangsa Bersatu untuk Pelarian Palestin (UNRWA) Philippe Lazzarini dalam satu hantaran di X.
Perkara itu dimaklumkan Pesuruhjaya Agung Agensi Bantuan dan Kerja Pertubuhan Bangsa-Bangsa Bersatu untuk Pelarian Palestin (UNRWA) Philippe Lazzarini dalam satu hantaran di X.
28 petugas dilapor maut dalam tempoh 24 jam lalu di Lubnan
28 petugas kesihatan dilaporkan terbunuh dalam tempoh 24 jam lalu di Lubnan.
Perkara itu dimaklumkan Ketua Pengarah Pertubuhan Kesihatan Sedunia (WHO) Tedros Adhanom Ghebreyesus pada Khamis.
Perkara itu dimaklumkan Ketua Pengarah Pertubuhan Kesihatan Sedunia (WHO) Tedros Adhanom Ghebreyesus pada Khamis.
UNIFIL kekal pada posisi walaupun didesak berundur
Pasukan pengaman PBB di selatan Lubnan terus bertahan pada kedudukan mereka, di bawah mandat UNSC, walaupun diarah Israel untuk berundur.
G7 desak pemain serantau di Asia Barat bertindak cermat dalam krisis
Pemimpin Kumpulan Tujuh (G7) mengulangi kebimbangan mereka terhadap krisis di Asia Barat dan menyeru pemain serantau supaya bertindak dengan bertanggungjawab serta berhemah.
Mereka turut menegaskan sokongan penuh terhadap keselamatan Israel.
Mereka turut menegaskan sokongan penuh terhadap keselamatan Israel.
AS sokong operasi Israel di Lubnan meski risiko meluaskan konflik
Pentadbiran Joe Biden menyatakan bahawa adalah wajar untuk Israel meneruskan serangan darat dan udara terhadap Hezbollah buat masa ini, menurut jurucakap Jabatan Negara Amerika Syarikat, Matthew Miller.
Namun, beliau mengakui risiko operasi di Lubnan mungkin melangkaui matlamat semasa Israel.
Namun, beliau mengakui risiko operasi di Lubnan mungkin melangkaui matlamat semasa Israel.
Shamsul Iskandar dakwa kesepakatan parti dalam PN kian longgar
Shamsul Iskandar berkata, perpecahan dalaman PN itu dapat diukur melalui prestasi mereka pada PRK DUN Nenggiri dan DUN Mahkota.
Politik stabil, dasar kerajaan tarik minat syarikat global melabur di Malaysia - Gobind
Menurut Menteri Digital Gobind Singh Deo, pada masa ini terdapat banyak perbincangan, tidak hanya antara syarikat-syarikat di negara serantau malah dunia berhubung perkara itu.
‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’
Golongan berisiko tinggi adalah individu yang mempunyai sejarah pembekuan darah dan mereka tidak dibenarkan menerima vaksin jenis AZ.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.